Jonathan M. Matthews

Jonathan M. Matthews

Auto-generated profile, based on publicly available information

Jonathan M. Matthews

Affiliations Pritzker School of Molecular Engineering, The University of Chicago, Chicago, Illinois, United States of America, Institute for Genomics and Systems Biology, The University of Chicago, Chicago, Illinois, United States of America, Pritzker School of Medicine, The University of Chicago, Chicago, Illinois, United States of America

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2022 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
JMJonathan M. Matthews
Jonathan M. Matthews
BSBrooke Schuster
Brooke Schuster
SKSara Saheb Kashaf
Sara Saheb Kashaf
PLPing Liu
Ping Liu
RBRakefet Ben-Yishay
Rakefet Ben-Yishay
STSavas Tay
Savas Tay
Organoids have immense potential as ex vivo disease models for drug discovery and personalized drug screening. Dynamic changes in individual organoid morphology, number, and size can indicate important drug responses. However, these metrics are difficult and labor-intensive to obtain for high-throughput image datasets. Here, we present OrganoID, a robust image analysis platform that automatically recognizes, labels, and tracks single organoids, pixel-by-pixel, in brightfield and phase-contrast microscopy experiments. The platform was trained on images of pancreatic cancer organoids and validated on separate images of pancreatic, lung, colon, and adenoid cystic carcinoma organoids, which showed excellent agreement with manual measurements of organoid count (95%) and size (97%) without any parameter adjustments. Single-organoid tracking accuracy remained above 89% over a four-day time-lapse microscopy study. Automated single-organoid morphology analysis of a chemotherapy dose-response experiment identified strong dose effect sizes on organoid circularity, solidity, and eccentricity. OrganoID enables straightforward, detailed, and accurate image analysis to accelerate the use of organoids in high-throughput, data-intensive biomedical applications.

16 January 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
JMJonathan Matthews
Jonathan Matthews
BSBrooke Schuster
Brooke Schuster
SKSara Saheb Kashaf
Sara Saheb Kashaf
PLPing Liu
Ping Liu
RBRakefet Ben-Yishay
Rakefet Ben-Yishay
STSavas Tay
Savas Tay
Organoids have immense potential as ex vivo disease models for drug discovery and personalized drug screening. Dynamic changes in individual organoid morphology, number, and size can indicate important drug responses, however these metrics are difficult and labor-intensive to obtain for high-throughput image datasets. Here, we present OrganoID, a robust image analysis platform that automatically recognizes, labels, and tracks single organoids, pixel-by-pixel, in brightfield and phase-contrast microscopy experiments. The platform was trained on images of pancreatic cancer organoids and validated on separate images of pancreatic, lung, colon, and adenoid cystic carcinoma organoids, which showed excellent agreement with manual measurements of organoid count (96%) and size (95%) without any parameter adjustments. Single-organoid tracking accuracy remained above 89% over a four-day time-lapse microscopy study. Automated single-organoid morphology analysis of a chemotherapy dose-response experiment identified decreased organoid circularity as an important morphological feature reflecting drug response. OrganoID enables straightforward, detailed, and accurate image analysis to accelerate the use of organoids in high-throughput, data-intensive biomedical applications.